PFE vs QCOM: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and QUALCOMM Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
VS
QUALCOMM Incorporated · Technology
$134.47
+45.0% upside to fair value
Med Conviction
Grade B
QuantHub Verdict
QCOM has more upside to fair value
(+45.0%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
QCOM |
| Current Price |
$26.33 |
$134.47 |
| Fair Value Estimate |
$33.85 |
$194.98 |
| Upside to Fair Value |
+28.6%
|
+45.0%
|
| Market Cap |
$149.8B |
$143.6B |
| Forward P/E |
19.3x
|
26.8x
|
| EV / EBITDA |
12.9x
|
—
|
| Price / Sales |
2.4x
|
3.2x
|
| Price / FCF |
16.5x
|
11.1x
|
| Revenue Growth YoY |
-1.2%
|
+8.7%
|
| Gross Margin |
70.3%
|
55.1%
|
| Operating Margin |
24.7%
|
27.1%
|
| Return on Equity |
8.7%
|
21.6%
|
| Dividend Yield |
0% |
— |
| FCF Yield |
6.06%
|
9.0%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Qualcomm Incorporated is a leading semiconductor company specializing in wireless chipsets and IP licensing, with dominant positions in 5G modems via QCT (87% of revenue) and steady QTL royalties. The business excels through a vast patent moat, diversification into automotive and IoT, and robust growth (revenue +13% YoY to $44B in FY2025), but faces risks from Apple modem shifts and China exposur…
Accumulation Zones
| Metric |
PFE |
QCOM |
| Zone Low |
$25.39 |
$146.23 |
| Zone High |
$28.77 |
$165.73 |
| In Buy Zone? |
Yes
|
Yes
|